EntreMed Commences Phase 2 Clinical T...

EntreMed Commences Phase 2 Clinical Trial Combining Panzem NCD and Temodar in Brain Cancer Patients

There are 1 comment on the Med Ad News story from May 31, 2007, titled EntreMed Commences Phase 2 Clinical Trial Combining Panzem NCD and Temodar in Brain Cancer Patients. In it, Med Ad News reports that:

EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the commencement of a Phase 2 combination study with ... via Med Ad News

Join the discussion below, or Read more at Med Ad News.

Bill Corrigan

Jersey City, NJ

#1 Jun 7, 2007
Great article!

Hi, I'm Bill Corrigan, board member of the Little Louie Foundation ~ Helping to fight pediatric brain cancer.

See the story about our foundation's $10,000 donation to cancer researcher Dr. Linda Van Aelst!

Visit http://billcorriganwhatsnew.blogspot.com/ today!

Tell your colleagues about how we can help researchers!

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

More from around the web